Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
Study Number: 

PH 275915

Trial categories: 
Leukemia
Acute Myeloid Leukemia (AML)
Immunotherapy
Antibody therapy
Principal Investigator: